Clinica 100: GE Healthcare focuses on organic growth and emerging markets to stay on top
This article was originally published in Clinica
Executive Summary
GE Healthcare has moved up in this year's Clinica 100 ranking from number three to number two in the medtech market, but will need to maintain growth to hold on to its spot. Its strategy includes targeting the emerging markets and focusing on organic growth, among other things, while keeping one eye on bolt-on acquisitions. Madeleine Armstrong spoke to president and CEO of GE Healthcare Europe, Jean-Michel Malbrancq, to find out more